MODD

Modular Medical, Inc. is a development-stage medical device company. The Company is focused on the design, development, and commercialization of insulin pumps using technology to increase pump adoption in the diabetes marketplace. The Company's product seeks to serve both the type 1 and type 2 diabetes markets for those individuals requiring insulin. MODD1, its product, is a high-precision pump. MODD1's features include two parts - one reusable, one disposable - snap together to form the working system; one button interface; 90-day reusable, three-day disposable; disposable portion removable at any time from an adhesive-backed retainer, which remains in place, and no external controller required, no charging and no battery replacement. MODD1 comes with a variety of methods for the patient to wear the pump. Options include a baseplate with adhesive for attaching to the body that has features for holding the pump to the patient, and overwraps to hold the product to the patient.

Wall Street analysts forecast MODD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MODD is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Modular Medical Inc revenue for the last quarter amounts to -7.83M USD, increased 56.71 % YoY.

Modular Medical Inc. EPS for the last quarter amounts to -6182000.00 USD, increased 57.42 % YoY.

Modular Medical Inc (MODD) has 54 emplpoyees as of January 10 2026.

Today MODD has the market capitalization of 37.92M USD.